<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">porozendo</journal-id><journal-title-group><journal-title xml:lang="ru">Остеопороз и остеопатии</journal-title><trans-title-group xml:lang="en"><trans-title>Osteoporosis and Bone Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-2680</issn><issn pub-type="epub">2311-0716</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/osteo13124</article-id><article-id custom-type="elpub" pub-id-type="custom">porozendo-13124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальное исследование</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original study</subject></subj-group></article-categories><title-group><article-title>Клинико-лабораторные особенности первичного гиперпаратиреоза в Тюменской области: ретроспективные данные трехлетнего наблюдения</article-title><trans-title-group xml:lang="en"><trans-title>Clinical and laboratory features of primary hyperparathyroidism in Tyumen region: retrospective data of a three-year follow-up</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8642-9435</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авдеева</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Avdeeva</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Авдеева Валерия Александровна, кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней Института клинической медицины</p><p>625023, г. Тюмень, ул. Одесская, д. 54 </p></bio><bio xml:lang="en"><p>Valeria A. Avdeeva, MD, PhD</p><p>54 Odesskaya street, 625023 Tyumen, Russia</p></bio><email xlink:type="simple">dr.avdeeva@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9253-8075</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суплотова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Suplotova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Суплотова Людмила Александровна, доктор медицинских наук, профессор </p><p>г. Тюмень</p></bio><bio xml:lang="en"><p>Liudmila A. Suplotova, MD, PhD, Professor</p><p>Tyumen</p></bio><email xlink:type="simple">suplotovala@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасенко</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasenko</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тарасенко Виктория Викторовна, студентка</p><p>г. Тюмень</p></bio><bio xml:lang="en"><p>Victoria V. Tarasenko</p><p>Tyumen</p></bio><email xlink:type="simple">tarasenko_viktoriya02@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никулин</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikulin</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>зНикулин Максим Олегович, заведующий хирургическим отделением №2</p><p>г. Тюмень</p></bio><bio xml:lang="en"><p>Maksim O. Nikulin</p><p>Tyumen</p></bio><email xlink:type="simple">nmo72@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Тюменский государственный медицинский университет<country>Россия</country></aff><aff xml:lang="en">Tyumen State Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ГБУЗ ТО «Областная клиническая больница №1»</aff><aff xml:lang="en">GBUZ TO «Regional clinical hospital no 1»</aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>20</day><month>04</month><year>2023</year></pub-date><volume>26</volume><issue>1</issue><fpage>24</fpage><lpage>30</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Авдеева В.А., Суплотова Л.А., Тарасенко В.В., Никулин М.О., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Авдеева В.А., Суплотова Л.А., Тарасенко В.В., Никулин М.О.</copyright-holder><copyright-holder xml:lang="en">Avdeeva V.A., Suplotova L.A., Tarasenko V.V., Nikulin M.O.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.osteo-endojournals.ru/jour/article/view/13124">https://www.osteo-endojournals.ru/jour/article/view/13124</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Недостаточное количество точных данных о распространенности первичного гиперпаратиреоза (ПГПТ), многообразие клинических форм, отсутствие рутинного биохимического скрининга уровня кальция в сыворотке крови, а также сложности в топическом поиске аденомы диктуют необходимость детального изучения клинико-лабораторных особенностей ПГПТ.</p></sec><sec><title>Цель</title><p>Цель. Оценить клиническое течение и лабораторные особенности пациентов с ПГПТ на территории Тюменской области.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведен ретроспективный анализ историй болезни 201 пациента с верифицированным гистологически диагнозом ПГПТ, находившихся на стационарном лечении в хирургическом отделении №2 в ГБУЗ ТО «Областная клиническая больница №1» г. Тюмени в период с 2019 по 2021 гг. Изучены демографические и антропо­метрические данные, оценены лабораторные (паратиреоидный гормон, общий и ионизированный кальций, 25(OH)D) и инструментальные (УЗИ щитовидной и околощитовидных желез, КТ и МРТ органов шеи с контрастированием и без него, сцинтиграфия околощитовидных желез с технетрилом) методы исследования.</p></sec><sec><title>Результаты</title><p>Результаты. Заболеваемость ПГПТ в Тюменской области составила 5,8 случая на 100 тыс. населения за 2019 г., в 2020 г. — 3,2 случая, в 2021 г. — 4,0 случая. Средний возраст всех пациентов с ПГПТ составил 60±11,05 года, 94,0% — женщины. Продолжительность заболевания от дебюта первых симптомов до момента постановки диагноза в среднем составила 2,0±1,3 года. Манифестная форма ПГПТ была выявлена у 80,1%, бессимптомная форма — у 17,9% обследуемых, нормокальциемическая — у 2,0% пациентов. Среди основных неклассических клинических проявлений, ассоциированных с ПГПТ, лидирующее место занимают заболевания сердечно-сосудистой системы (n=157), проявляющиеся в виде ишемической болезни сердца, гипертрофии левого желудочка, хронической сердечной недостаточности в 68,1% случаев; в 86,9% — артериальной гипертензией и нарушениями сердечного ритма — у 6,9% пациентов. Только у 13,9% (n=28) был исследован уровень 25(ОН)D, из которых у 68% диагностировано состояние его дефицита или недостаточности.</p></sec><sec><title>Заключение</title><p>Заключение. Клинические проявления ПГПТ, в том числе ассоциированные с кардиоваскулярной патологией, диктуют необходимость рутинного исследования уровня кальция у данной категории пациентов, а также уточнения патогенетических механизмов, лежащих в основе этой взаимосвязи. Имеющиеся данные о вкладе дефицита витамина D в развитие и прогрессирование ПГПТ на до- и послеоперационном этапе свидетельствуют о необходимости обязательного исследования 25(OH)D у данной категории пациентов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background: The lack of accurate data on the prevalence of primary hyperparathyroidism (PHPT), the variety of clinical forms, the lack of routine biochemical screening of serum calcium levels, as well as the difficulty in the topical search for adenoma dictate the need for a detailed study of the clinical and laboratory features of PHPT.</p></sec><sec><title>Aim</title><p>Aim: Assess the clinical course and laboratory features of patients with PHPT in Tyumen region.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: A retrospective analysis of the case histories of 201 patients with PHPT who were hospitalized in the surgical department No. 2 at the Regional Clinical Hospital No. 1 in Tyumen in the period 2019–2021 was carried out. demographic and anthropometric data were studied, laboratory data (PTH, levels of total and ionized calcium, 25(OH)D) and instrumental (ultrasound) of the thyroid and parathyroid glands, CT and MRI of the neck organs with and without contrast were evaluated, scintigraphy of the parathyroid glands with technetrile) diagnostic methods.</p></sec><sec><title>Results</title><p>Results: The incidence of PHPT in the Tyumen region was 5.8 cases per 100 thousand population in 2019, in 2020. — 3.2 cases in 2021 — 4.0 cases. The average age of all patients with PHPT was 60±11.05 years, 94.0% were women. The duration of the disease from the onset of the first symptoms to the time of diagnosis, on average, was 2.0±1.3 years. The manifest form of PHPT was detected in 80.1%, asymptomatic form in 17.9% of the examined, normocalcemic in 2.0% of patients. Among the main clinical manifestations of PHPT, the leading place is occupied by diseases of the cardiovascular system (n=157), ­manifested in the form of coronary heart disease, left ventricular hypertrophy, chronic heart failure in 68.1% of cases; in 86.9% arterial hypertension and cardiac arrhythmias in 6.9% of patients. Of the total number of patients, only 13.9% (n=28) had the level of 25(OH)D examined, of which 68% were diagnosed with a state of its deficiency or insufficiency.</p></sec><sec><title>Conclusion</title><p>Conclusion: Clinical manifestations of PHPT in the form of cardiovascular pathology dictate the need for a routine study of calcium levels in this category of patients, as well as clarification of the pathogenetic mechanisms underlying this relationship. The available data on the contribution of vitamin D deficiency to the development and progression of PHPT at the pre- and postoperative stage indicate need for study of 25(OH)D in this category of patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>первичный гиперпаратиреоз</kwd><kwd>паратиреоидный гормон</kwd><kwd>25(ОН)D</kwd><kwd>кальций крови</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primary hyperparathyroidism</kwd><kwd>parathyroid hormone</kwd><kwd>vitamin D</kwd><kwd>blood calcium</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Словари и энциклопедии. Доступно по: https://slovarozhegova.ru/word.php?wordid=36312 Ссылка активна на 08.05.2023.</mixed-citation><mixed-citation xml:lang="en">Slovari i jenciklopedii (In Russ.). https://slovarozhegova.ru/word.php?wordid=36312 Ссылка активна на 08.05.2023.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Мокрышева Н.Г., Крупинова Ю.А. История открытия околощитовидных желез и их роль в организме // Вестник РАМН. — 2019. — Т. 74. — №1. — С. 35-43. https://doi.org/10.15690/vramn1072</mixed-citation><mixed-citation xml:lang="en">Mokrysheva NG, Krupinova JA. The history of the discovery of parathyroid glands, and their role in the body. Ann Russ Acad Med Sci. 2019;74(1):35-43. (In Russ.). https://doi.org/10.15690/vramn1072</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ МЗ РФ от 27.04.2021 г. № 404н. Об утверждении порядка проведения диспансеризации определенных групп взрослого населения.. Доступно по: https://docs.cntd.ru/document/607124051. Ссылка активна на 08.10.2022.</mixed-citation><mixed-citation xml:lang="en">Prikaz MZ RF ot 27.04.2021 g. № 404n. Ob utverzhdenii porjadka provedenija dispanserizacii opredelennyh grupp vzroslogo naselenija. (In Russ.). Доступно по: https://docs.cntd.ru/document/607124051. Ссылка активна на 08.10.2022.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115-125. https://doi.org/10.1038/nrendo.2017</mixed-citation><mixed-citation xml:lang="en">Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115-125. https://doi.org/10.1038/nrendo.2017</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Мокрышева Н.Г., Еремкина А.К.,Мирная С.С., и др. Клинические рекомендации по первичному гиперпаратиреозу, краткая версия // Проблемы эндокринологии. — 2021. — Т. 67. — №4. — С. 94-124. https://doi.org/10.14341/probl12801</mixed-citation><mixed-citation xml:lang="en">Mokrysheva NG, Eremkina AK, Mirnaya SS, et al. The clinical practice guidelines for primary hyperparathyroidism, short version. Problems of Endocrinology. 2021;67(4):94-124. (In Russ.). https://doi.org/10.14341/probl12801</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bilezikian JP. Primary hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993-4004. https://doi.org/10.1210/jc.2018-01225</mixed-citation><mixed-citation xml:lang="en">Bilezikian JP. Primary hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993-4004. https://doi.org/ 10.1210/jc.2018-01225</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1-19. https://doi.org/10.1007/s00198-016-3716-2</mixed-citation><mixed-citation xml:lang="en">Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1-19. https://doi.org/10.1007/s00198-016-3716-2</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Баранова И.А., Клемушина Т.В., Зыкова Т.А. Эпидемиология первичного гиперпаратиреоза — невидимая часть айсберга (обзор литературы) // Медицинский вестник Юга России. — 2016. — №2 — С. 4-8. https://doi.org/10.21886/2219-8075-2016-2-4-8</mixed-citation><mixed-citation xml:lang="en">Baranova IA, Klemushina TV, Zykova TA. Epidemiology of primary hyperparathyroidism — invisible part of the iceberg (literature rewiew). Medical Herald of the South of Russia. 2016;(2):4-8. (In Russ.). https://doi.org/10.21886/2219-8075-2016-2-4-8</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Мокрышева Н.Г., Мирная С.С., Добрева Е.А., и др. Первичный гиперпаратиреоз в России по данным регистра // Проблемы эндокринологии. — 2019. — Т. 65. — №5. — С. 300-310. https://doi.org/10.14341/probl10126</mixed-citation><mixed-citation xml:lang="en">Mokrysheva NG, Mirnaya SS, Dobreva EA, et al. Primary hyperparathyroidism in Russia according to the registry. Problems of Endocrinology. 2019;65(5):300-310. (In Russ.). https://doi.org/10.14341/probl10126</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Мамедова Е.О., Мокрышева Н.Г., Рожинская Л.Я. Особенности первичного гиперпаратиреоза у пациентов молодого возраста // Проблемы эндокринологии. — 2018. — Т. 64. — № 3. — С.163-169. https://doi.org/10.14341/probl9399</mixed-citation><mixed-citation xml:lang="en">Mamedova EO, Mokrysheva NG, Rozhinskaya LY. Characteristics of primary hyperparathyroidism in young patients. Problems of Endocrinology. 2018;64(3):163-169. (In Russ.). https://doi.org/10.14341/probl9399</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yavropoulou MP, Anastasilakis AD, Panagiotakou A, et al. Gender predilection in sporadic parathyroid adenomas. Int J Mol Sci. 2020;21(8):2964. https://doi.org/10.3390/ijms21082964.</mixed-citation><mixed-citation xml:lang="en">Yavropoulou MP, Anastasilakis AD, Panagiotakou A, et al. Gender predilection in sporadic parathyroid adenomas. Int J Mol Sci. 2020;21(8):2964. https://doi.org/10.3390/ijms21082964.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Marcocci C, Saponaro F. Epidemiology, pathogenesis of primary hyperparathyroidism: Current data. Ann Endocrinol (Paris). 2015;76(2):113-115. https://doi.org/10.1016/j.ando.2015.03.015</mixed-citation><mixed-citation xml:lang="en">Marcocci C, Saponaro F. Epidemiology, pathogenesis of primary hyperparathyroidism: Current data. Ann Endocrinol (Paris). 2015;76(2):113-115. https://doi.org/10.1016/j.ando.2015.03.015</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Castellano E, Attanasio R, Boriano A, et al. Sex Difference in the Clinical Presentation of Primary Hyperparathyroidism: Influence of Menopausal Status. J Clin Endocrinol Metab. 2017;102(11):4148-4152. https://doi.org/10.1210/jc.2017-01080</mixed-citation><mixed-citation xml:lang="en">Castellano E, Attanasio R, Boriano A, et al. Sex Difference in the Clinical Presentation of Primary Hyperparathyroidism: Influence of Menopausal Status. J Clin Endocrinol Metab. 2017;102(11):4148-4152. https://doi.org/10.1210/jc.2017-01080</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Яневская Л.Г., Каронова Т.Л., Слепцов И.В., и др. Первичный гиперпаратиреоз: клинические формы и их особенности. Результаты ретроспективного исследования // Клиническая и экспериментальная тиреоидология. — 2019. — Т.15. — №1. — С. 19-29. https://doi.org/10.14341/ket10213</mixed-citation><mixed-citation xml:lang="en">Yanevskaya LG, Karonova TL, Sleptsov IV, et al. Primary hyperparathyroidism: clinical forms and their features. Retrospective study. Clinical and experimental thyroidology. 2019;15(1):19-29. (In Russ.). https://doi.org/10.14341/ket10213</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Makras P, Anastasilakis AD. Bone disease in primary hyperparathyroidism. Metabolism. 2018;80(11):57-65. https://doi.org/10.1016/j.metabol.2017.10.003</mixed-citation><mixed-citation xml:lang="en">Makras P, Anastasilakis AD. Bone disease in primary hyperparathyroidism. Metabolism. 2018;80(11):57-65. https://doi.org/10.1016/j.metabol.2017.10.003</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bennett J, Suliburk JW, Morón FE. Osseous manifestations of primary hyperparathyroidism: imaging findings. Int J Endocrinol. 2020;2020(11):1-10. https://doi.org/10.1155/2020/3146535</mixed-citation><mixed-citation xml:lang="en">Bennett J, Suliburk JW, Morón FE. Osseous manifestations of primary hyperparathyroidism: imaging findings. Int J Endocrinol. 2020;2020(11):1-10. https://doi.org/10.1155/2020/3146535</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gianotti L, Tassone F, Baffoni C, et al. Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf). 2014;81(3):350-355. https://doi.org/10.1111/cen.12472</mixed-citation><mixed-citation xml:lang="en">Gianotti L, Tassone F, Baffoni C, et al. Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf). 2014;81(3):350-355. https://doi.org/10.1111/cen.12472</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Duran C, Sevinc B, Kutlu O, et al. Parathyroidectomy decreases insulin resistance index in patients with primary hyperparathyroidism. Indian J Surg. 2017;79(2):101-105. https://doi.org/10.1007/s12262-015-1431-4</mixed-citation><mixed-citation xml:lang="en">Duran C, Sevinc B, Kutlu O, et al. Parathyroidectomy decreases insulin resistance index in patients with primary hyperparathyroidism. Indian J Surg. 2017;79(2):101-105. https://doi.org/10.1007/s12262-015-1431-4</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Beysel S, Caliskan M, Kizilgul M, et al. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord. 2019;19(1):106. https://doi.org/10.1186/s12872-019-1093-4</mixed-citation><mixed-citation xml:lang="en">Beysel S, Caliskan M, Kizilgul M, et al. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord. 2019;19(1):106. https://doi.org/10.1186/s12872-019-1093-4</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Dural C, Okoh AK, Seicean A, et al. A pilot study investigating the effect of parathyroidectomy on arterial stiffness and coronary artery calcification in patients with primary hyperparathyroidism. Surgery. 2016;159(1):218-225. https://doi.org/10.1016/j.surg.2015.07.037</mixed-citation><mixed-citation xml:lang="en">Dural C, Okoh AK, Seicean A, et al. A pilot study investigating the effect of parathyroidectomy on arterial stiffness and coronary artery calcification in patients with primary hyperparathyroidism. Surgery. 2016;159(1):218-225. https://doi.org/10.1016/j.surg.2015.07.037</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mesquita PN, Dornelas Leão Leite AP, das Chagas Crisostomo S, et al. Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism. Vasc Health Risk Manag. 2017;(13):225-229. https://doi.org/10.2147/VHRM.S128084</mixed-citation><mixed-citation xml:lang="en">Mesquita PN, Dornelas Leão Leite AP, das Chagas Crisostomo S, et al. Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism. Vasc Health Risk Manag. 2017;(13):225-229. https://doi.org/10.2147/VHRM.S128084</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959. https://doi.org/10.1001/jamasurg.2016.2310</mixed-citation><mixed-citation xml:lang="en">Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959. https://doi.org/10.1001/jamasurg.2016.2310</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Каронова Т.Л., Погосян К.А., Яневская Л.Г., и др. Механизмы повреждения сердечно-сосудистой системы при заболеваниях околощитовидных желез // Артериальная гипертензия. — 2021. — Т. 27. — №1. — С. 64-72. https://doi.org/10.18705/1607-419X-2021-27-1-64-72</mixed-citation><mixed-citation xml:lang="en">Karonova TL, Pogosian KA, Yanevskaya LG, et al. Parathyroid gland disorders and cardiovascular disease. Arterial Hypertens. 2021;27(1):64-72. (In Russ.). https://doi.org/10.18705/1607-419X-2021-27-1-64-72</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Добрева Е.А., Еремкина А.К., Мирная С.С., и др. Кардиоваскулярные нарушения у пациентов с первичным гиперпаратиреозом по данным регистра. // Профилактическая медицина. — 2020. — Т. 23. — №6. — С. 26-35. https://doi.org/10.17116/profmed20202306226</mixed-citation><mixed-citation xml:lang="en">Dobreva EA, Eremkina AK, Mirnaya SS, et al. Cardiovascular disorders in patients with primary hyperparathyroidism according to registry data. Profilakticheskaya Meditsina. 2020;23(6):26-35. (In Russ.). doi: https://doi.org/10.17116/profmed20202306226</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Bone HG, Wagman R, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. The Lancet Diabetes &amp; Endocrinology. 2017;5(7):513-523. https://doi.org/10.1016/S2213-8587(17)30138-9</mixed-citation><mixed-citation xml:lang="en">Bone HG, Wagman R, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. The Lancet Diabetes &amp; Endocrinology. 2017;5(7):513-523. https://doi.org/10.1016/S2213-8587(17)30138-9</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Pepe J, Cipriani C, Sonato C, et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol. 2017;177(6):297-308. https://doi.org/10.1530/EJE-17-0485</mixed-citation><mixed-citation xml:lang="en">Pepe J, Cipriani C, Sonato C, et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol. 2017;177(6):297-308. https://doi.org/10.1530/EJE-17-0485</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Saxena T, Ali AO, Saxena M. Pathophysiology of essential hypertension: an update. Expert Rev Cardiovasc Ther. 2018;16(12):879-887. https://doi.org/10.1080/14779072.2018.1540301</mixed-citation><mixed-citation xml:lang="en">Saxena T, Ali AO, Saxena M. Pathophysiology of essential hypertension: an update. Expert Rev Cardiovasc Ther. 2018;16(12):879-887. https://doi.org/10.1080/14779072.2018.1540301</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">McMahon DJ, Carrelli A, Palmeri N, et al. Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab. 2015;100(12):4399-4407. https://doi.org/10.1210/jc.2015-3202</mixed-citation><mixed-citation xml:lang="en">McMahon DJ, Carrelli A, Palmeri N, et al. Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab. 2015;100(12):4399-4407. https://doi.org/10.1210/jc.2015-3202</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Walker MD, Cong E, Lee JA, et al. Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J Clin Endocrinol Metab. 2015;100(9):3443-3451. https://doi.org/10.1210/jc.2015-2022</mixed-citation><mixed-citation xml:lang="en">Walker MD, Cong E, Lee JA, et al. Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J Clin Endocrinol Metab. 2015;100(9):3443-3451. https://doi.org/10.1210/jc.2015-2022</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Viccica G, Cetani F, Vignali E, et al. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine. 2017;55(1):256-265. https://doi.org/10.1007/s12020-016-0931-8</mixed-citation><mixed-citation xml:lang="en">Viccica G, Cetani F, Vignali E, et al. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine. 2017;55(1):256-265. https://doi.org/10.1007/s12020-016-0931-8</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Randle RW, Balentine CJ, Wendt E. Should vitamin D deficiency be corrected before parathyroidectomy? J Surg Res. 2016;204(1):94-100. https://doi.org/10.1016/j.jss.2016.04.022</mixed-citation><mixed-citation xml:lang="en">Randle RW, Balentine CJ, Wendt E. Should vitamin D deficiency be corrected before parathyroidectomy? J Surg Res. 2016;204(1):94-100. https://doi.org/10.1016/j.jss.2016.04.022</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho GB, Giraldo LR, Lira RB, et al. Preoperative vitamin D deficiency is a risk factor for postoperative hypocalcemia in patients undergoing total thyroidectomy: retrospective cohort study. Sao Paulo Med J. 2019;137(3):241-224. https://doi.org/10.1590/1516-3180.2018.0336140319</mixed-citation><mixed-citation xml:lang="en">Carvalho GB, Giraldo LR, Lira RB, et al. Preoperative vitamin D deficiency is a risk factor for postoperative hypocalcemia in patients undergoing total thyroidectomy: retrospective cohort study. Sao Paulo Med J. 2019;137(3):241-224. https://doi.org/10.1590/1516-3180.2018.0336140319</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
